Merck & Co. / Johnson & Johnson / Pearl Therapeutics / 5AM Ventures / Amgen / Cubist Pharmaceuticals / Advanced Inhalation Research Inc. / Decode Genetics / Pulmatrix Inc. / Alkermes Inc. / Dawson James Securities Inc. / Ruthigen Inc. / Transform Pharmaceuticals / Polaris Partners / Pulmatrix Enter / Inspire Pharmaceuticals / Palladium Capital Advisors LLC / AstraZeneca / NASDAQ Capital Market / /
Currency
USD / /
Event
Employment Change / M&A / Name Change / Funding / FDA Phase / /
Pulmatrix's mission / U.S. Securities and Exchange Commission / /
Person
Terry McGuire / Sameer Harish / Robert Clarke / Hoji Alimi / Scott Rocklage / / /
Position
agent and financial advisor / advisor / board member / managing partner / Director of Life Sciences / CEO and Chairman / President and Chief Executive Officer / Chairman & CEO / senior board member / former Chairman & CEO / co-founder / /
Product
PUR0200 / Pulmatrix / /
ProvinceOrState
Massachusetts / /
Technology
dry powder inhaler technologies / iSPERSE technology / biotechnology / drug delivery / drug development / /